AR051928A1 - Peptidos y derivados tipo apl de la hsp60 y composiciones farmaceuticas - Google Patents
Peptidos y derivados tipo apl de la hsp60 y composiciones farmaceuticasInfo
- Publication number
- AR051928A1 AR051928A1 ARP050103950A ARP050103950A AR051928A1 AR 051928 A1 AR051928 A1 AR 051928A1 AR P050103950 A ARP050103950 A AR P050103950A AR P050103950 A ARP050103950 A AR P050103950A AR 051928 A1 AR051928 A1 AR 051928A1
- Authority
- AR
- Argentina
- Prior art keywords
- peptides
- pharmaceutical compositions
- hsp60
- derivatives
- rheumatoid arthritis
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102000006303 Chaperonin 60 Human genes 0.000 title 1
- 108010058432 Chaperonin 60 Proteins 0.000 title 1
- 230000007246 mechanism Effects 0.000 abstract 2
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 2
- 206010011968 Decreased immune responsiveness Diseases 0.000 abstract 1
- 102000003839 Human Proteins Human genes 0.000 abstract 1
- 108090000144 Human Proteins Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 210000003289 regulatory T cell Anatomy 0.000 abstract 1
- 230000008646 thermal stress Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Péptidos de la proteína humana de estrés térmico de 60 kDa que constituyen epitopes para células T, así como péptidos derivados de ellos, los cuales están modificados en los sitios de contacto con la molécula MHC, utiles para inducir mecanismos de tolerancia periférica, en particular mecanismos inductores de anergia o mediados por clones de célula T regulatorias en pacientes con Artritis Reumatoide. La presente también refiere composiciones farmacéuticas que comprenden tales péptidos para tratamiento de la Artritis Reumatoide.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20040207A CU23504A1 (es) | 2004-09-24 | 2004-09-24 | Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051928A1 true AR051928A1 (es) | 2007-02-21 |
Family
ID=40273413
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050103950A AR051928A1 (es) | 2004-09-24 | 2005-09-21 | Peptidos y derivados tipo apl de la hsp60 y composiciones farmaceuticas |
| ARP090105137A AR074924A2 (es) | 2004-09-24 | 2009-12-28 | Peptidos y derivados tipo peptido ligando alterado (apl) de la hsp60 y composiciones farmaceuticas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090105137A AR074924A2 (es) | 2004-09-24 | 2009-12-28 | Peptidos y derivados tipo peptido ligando alterado (apl) de la hsp60 y composiciones farmaceuticas |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8383771B2 (es) |
| EP (2) | EP2371847B1 (es) |
| JP (1) | JP4755649B2 (es) |
| KR (2) | KR101054332B1 (es) |
| CN (2) | CN101065398B (es) |
| AR (2) | AR051928A1 (es) |
| AT (1) | ATE546462T1 (es) |
| AU (2) | AU2005287757B2 (es) |
| BR (2) | BRPI0515893B8 (es) |
| CA (2) | CA2797769C (es) |
| CU (1) | CU23504A1 (es) |
| DK (2) | DK2371847T3 (es) |
| ES (2) | ES2445707T3 (es) |
| MX (1) | MX2007003624A (es) |
| RU (1) | RU2361877C2 (es) |
| WO (1) | WO2006032216A2 (es) |
| ZA (1) | ZA200702938B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2423222B2 (en) | 2007-01-30 | 2020-07-29 | Epivax, Inc. | Regulatory t cell epitopes, compositions and uses thereof |
| CU23701A1 (es) * | 2008-12-29 | 2011-09-21 | Ct Ingenieria Genetica Biotech | Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i |
| BR112012004983A2 (pt) * | 2009-09-06 | 2021-02-23 | Protab Ltd. | anticorpos humanizados específicos para métodos de pepetídeo-6 derivado de hsp65 |
| US20110195905A1 (en) * | 2009-10-28 | 2011-08-11 | Argentis Pharmaceuticals, Llc | Apls for treating arthritis |
| CU24508B1 (es) * | 2017-12-29 | 2021-04-07 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición farmacéutica que comprende péptido tipo apl |
| CU20200026A7 (es) * | 2020-04-13 | 2021-11-04 | Ct Ingenieria Genetica Biotecnologia | Péptido para el tratamiento del síndrome de la tormenta de citocinas |
| CN111870697B (zh) * | 2020-09-18 | 2022-09-09 | 山东鲁抗医药股份有限公司 | 糖类物质在提高apl型衍生肽稳定性中的应用和冻干组合物 |
| KR102333645B1 (ko) | 2021-07-27 | 2021-12-02 | (주)문화전기 | 각도조절이 용이한 엘이디조명시스템 |
| CN117883547A (zh) * | 2021-07-30 | 2024-04-16 | 河北菲尼斯生物技术有限公司 | Se-dr亲和肽在制备治疗风湿疾病的药物中的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8701163A (nl) | 1986-09-09 | 1988-04-05 | Nederlanden Staat | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
| NL8703107A (nl) | 1987-12-22 | 1989-07-17 | Nederlanden Staat | Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten. |
| US5773570A (en) | 1994-05-20 | 1998-06-30 | The Regents Of The University Of California | Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| GB9419553D0 (en) | 1994-09-27 | 1994-11-16 | Univ Bristol | Polypeptides and their use in the treatment of auto-immune disease |
| US6180103B1 (en) | 1994-12-21 | 2001-01-30 | Yeda Research And Development Co., Ltd. | Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
| GB9519737D0 (en) | 1995-09-27 | 1995-11-29 | Peptide Therapeutics Ltd | Polypeptides and their use in treatment and prophylaxis of auto-immune |
| US5993803A (en) | 1996-08-30 | 1999-11-30 | Yeda Research And Development Co., Ltd. | Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity |
| GB9911772D0 (en) | 1999-05-21 | 1999-07-21 | Semmelweis University Of Medic | Diagnosis and treatment of atherosclerosis |
| US20020169302A1 (en) * | 1999-08-23 | 2002-11-14 | Genesis Research And Development Corp. Ltd. | Compositions isolated from bovine mammary gland and methods for their use |
| CA2394504A1 (en) * | 1999-12-15 | 2001-06-21 | Peptor Ltd. | Fragments and antagonists of heat shock protein 60 |
| AU2002247004A1 (en) | 2001-01-19 | 2002-07-30 | Cambridge Scientific, Inc. | Methods of diagnosis and treatment of osteoporosis |
-
2004
- 2004-09-24 CU CU20040207A patent/CU23504A1/es active IP Right Grant
-
2005
- 2005-09-21 AR ARP050103950A patent/AR051928A1/es active IP Right Grant
- 2005-09-22 CN CN2005800403891A patent/CN101065398B/zh active Active
- 2005-09-22 KR KR1020077008682A patent/KR101054332B1/ko active IP Right Grant
- 2005-09-22 JP JP2007532752A patent/JP4755649B2/ja active Active
- 2005-09-22 BR BRPI0515893A patent/BRPI0515893B8/pt active IP Right Grant
- 2005-09-22 DK DK10189769.2T patent/DK2371847T3/da active
- 2005-09-22 ES ES10189769.2T patent/ES2445707T3/es active Active
- 2005-09-22 MX MX2007003624A patent/MX2007003624A/es active IP Right Grant
- 2005-09-22 US US11/663,603 patent/US8383771B2/en active Active
- 2005-09-22 EP EP10189769.2A patent/EP2371847B1/en active Active
- 2005-09-22 CN CN2010100038161A patent/CN101935345B/zh active Active
- 2005-09-22 CA CA2797769A patent/CA2797769C/en active Active
- 2005-09-22 RU RU2007115411/04A patent/RU2361877C2/ru active
- 2005-09-22 AT AT05794474T patent/ATE546462T1/de active
- 2005-09-22 KR KR1020107001135A patent/KR101035283B1/ko active IP Right Grant
- 2005-09-22 DK DK05794474.6T patent/DK1803732T3/da active
- 2005-09-22 BR BR122018077204A patent/BR122018077204B8/pt active IP Right Grant
- 2005-09-22 WO PCT/CU2005/000008 patent/WO2006032216A2/es active Application Filing
- 2005-09-22 EP EP05794474A patent/EP1803732B1/en active Active
- 2005-09-22 CA CA2581110A patent/CA2581110C/en active Active
- 2005-09-22 AU AU2005287757A patent/AU2005287757B2/en not_active Ceased
- 2005-09-22 ES ES05794474T patent/ES2386498T3/es active Active
-
2007
- 2007-04-10 ZA ZA200702938A patent/ZA200702938B/xx unknown
-
2009
- 2009-12-28 AR ARP090105137A patent/AR074924A2/es active IP Right Grant
- 2009-12-30 US US12/649,687 patent/US8324164B2/en active Active
-
2010
- 2010-09-06 AU AU2010219312A patent/AU2010219312B2/en not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR051928A1 (es) | Peptidos y derivados tipo apl de la hsp60 y composiciones farmaceuticas | |
| ECSP099379A (es) | Anticuerpos anti-factor d humanizados | |
| CO6280409A2 (es) | Anticuerpos antimesotelina y usos de los mismos | |
| EA201270713A1 (ru) | Белки на основе фибронектина с каркасными доменами, которые связывают ил-23 | |
| CY1119739T1 (el) | Καινοτομος ανοσοθεραπεια εναντι ογκων του εγκεφαλου | |
| CR11817A (es) | Anticuerpos anti-factor d humanizados y sus usos | |
| PE20081501A1 (es) | Polipeptidos heterologos il-17a/f y usos terapeuticos de los mismos | |
| CY1117115T1 (el) | Καινοτομος ανοσοθεραπεια εναντι ογκων και νευρωνων του εγκεφαλου | |
| AR067666A1 (es) | Proteinas de union al antigeno del receptor de il-18 | |
| CO7121348A2 (es) | Proteínas de fusión de interleuquina-2 y usos de las mismas | |
| CL2021001794A1 (es) | Péptido, ácido nucleico, célula, composición farmacéutica, linfocito t activado, agente de unión aislado, y tcr, para su uso en inmunoterapia contra el cáncer; y métodos para producirlos (divisional de la solicitud no. 201600227) | |
| BR112018072946A2 (pt) | proteínas de fusão a gdf15 e usos das mesmas | |
| EA201892619A1 (ru) | Иммуноконъюгаты, содержащие мутантные полипептиды интерлейкина-2 | |
| AR079114A1 (es) | Proteinas de enlace de antigenos anti-orai1 y usos de las mismas | |
| EA201591766A1 (ru) | Мутеины интерлейкина-2 для экспансии регуляторных т-клеток | |
| AR071874A1 (es) | Proteinas de dominio de armazon basadas en fibronectina multivalentes | |
| CL2013003634A1 (es) | Complejo que comprende una proteina de fusion que comprende, un peptido viral, peptido conector, microglobulina beta 2 , peptido conector, dominios extracelulares alfa 1, 2 y 3 de mhc de clase i y un tercer peptido conector; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso | |
| CU20120116A7 (es) | Polipéptidos que se enlazan a dr5 humana con efectos agonistas, que comprenden uno o más monómeros de un único dominio variable, utiles en el tratamiento de enfermedades y trastornos asociados con dr5 | |
| BR112015021819A2 (pt) | Tratamento de câncer utilizando receptor quimérico de antígeno humanizado anti-cd19 | |
| PE20140303A1 (es) | Polipeptidos interleuquina-2 mutantes | |
| BR112012009854B8 (pt) | proteína de ligação de antígeno isolada recombinante que liga il-23, composição farmacêutica, molécula de ácido nucleico isolada recombinante, vetor recombinante, método de confecção da referida proteína de ligação e uso da mesma | |
| BR112012016135A2 (pt) | proteínas de ligação de heterodímero e seus usos | |
| BRPI0508670A (pt) | proteìnas de buganina modificada, citotoxinas e métodos e usos delas | |
| CL2009001277A1 (es) | Anticuerpo que enlaza especificamente el flt3 humano; fragmento de cualquiera de los anticuerpos antes dichos; acido polinucleico aislado; vector de expresion; celula recombinante; composicion farmaceutica y sus usos; producto que contiene el anticuerpo para tratar cancer | |
| PE20121636A1 (es) | Polipeptidos inmunomoduladores derivados de la il-2 y su uso terapeutico en cancer y en infecciones cronicas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |